Meet FinnGen at the ESHG 2026!

FinnGen at ESHG 2026: discover our latest science through talks and posters across the programme!
Promotional graphic for “ESHG 2026” (European Human Genetics Conference) with the text “I am attending ESHG 2026” and event details “June 13–16, Svenska Mässan, Gothenburg, Sweden.” The design features a red-to-purple gradient background, a stylized city skyline illustration on the left, the ESHG logo at the top center, and the FinnGen logo on the right.

FINNGEN PLATFORM PRESENTATIONS 

Saturday Jun 13 

Yining Wang - More is more: Shared phenotypes amongst sex chromosome trisomies hints dosage-sensitive effect of pseudoautosomal regions in genetic males and females 

Concurrent Sessions C03: Sex and the Cyto, F1-3 at 11-11:15  

 

Joonas Kartau - Fine-mapping a breast cancer GWAS meta-analysis combining FinnGen and UK Biobank 

LTB1.1 Lightning Talks B1: Large-scale association studies & Population genetics, Lightning Talks Stage at 16:00 - 16:05  

 

Elisa Moreno - Genome-wide association meta-analyses over one million individuals identifies 54 loci associated with urinary incontinence and its subtypes 

Concurrent Sessions C08: GWAS at Scale: Discovery, Diversity, and Integration, Hall C at 19:00 – 19:15  

 
Sunday Jun 14 

Nina Mars - Risk-Stratified Breast-Cancer Screening: Evidence from the FinnGen Cohort 

Concurrent Symposia - S07:  Polygenic scores: are we there yet for clinical implementation, Hall C at 15:00 – 15:30 

 

Monday Jun 15 

Erja Nynäs - PALB2 and CHEK2 variants confer multicancer risk with high lifetime risks 

Concurrent Sessions C33: Germline and environmental risk factors in cancer, H1+2 at 11:00 – 11:15  

  

Sannimari Suhonen - The protective effects of low polygenic risk scores in susceptibility gene variant carriers across 10 diseases 

Concurrent Sessions C32: Polygenic Risk and Complex Inheritance, F4+5 at 11:15 – 11:30  

 

FINNGEN POSTERS 

Saturday Jun 13: Poster session PV01, Group A, Exhibition Hall at 12:15 - 13:15 PM 

Eemeli S. Tusa - Polygenic risk impacts lifetime risk and prognosis of glaucoma [Presentation No. P04.007.A] 

 

Saturday Jun 13: Poster session PV02, Group B, Exhibition Hall at 16:00 - 17:00 PM 

Joonas Kartau - Fine-mapping a breast cancer GWAS meta-analysis combining FinnGen and UK Biobank [Presentation No. P15.020.B] 

Marika Annika Kaakinen - Genetic validation of evidence-based phenotype refinement in EHR data [Presentation No. P15.086.B] 

 

Sunday Jun 14: Poster session PV03, Group C, Exhibition Hall at 12:45 - 13:45  

A K Rafeul Hasan - Genetic architecture of 5-alpha reductase inhibitor users: a GWAS of the Finnish population [Presentation No. P17.021.C]  

Anastasiia Alekseienko - Leveraging nationwide health care records in Estonia to identify the genetic background of understudied disease phenotypes [Presentation No. P16.099.C]  

 

Sunday Jun 14: Poster session PV04, Group D, Exhibition Hall at 15:45 - 16:45  

Katri Ruokamo-Korva - Genetic determinants of longitudinal antibiotic use patterns: a large-scale multi-cohort genome-wide association study [Presentation No. P16.058.D] 

Hina Ishtiaq - Large scale variant discovery through Genome wide Association Study and multiomics approaches in recessive retinal dystrophy [Presentation No. P20.046.D] 

 

Monday Jun 15: Poster session PV06, Group F, Exhibition Hall at 15:45 - 16:45  

Tuomo Hartonen - Sex-related signatures in the plasma proteome not attributable to XX and XY chromosomes and their impact on health and disease [Presentation No. P16.060.F]